Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35
Filtrar
2.
Am J Med Genet A ; 185(10): 3048-3052, 2021 10.
Artículo en Inglés | MEDLINE | ID: mdl-34032360

RESUMEN

Noonan syndrome (NS) is one of the common RASopathies. While the clinical phenotype in NS is variable, it is typically characterized by distinctive craniofacial features, cardiac defects, reduced growth, bleeding disorders, learning issues, and an increased risk of cancer. Several different genes cause NS, all of which are involved in the Ras/mitogen-activated protein kinase (Ras/MAPK) pathway. Juvenile xanthogranuloma (JXG) is an uncommon, proliferative, self-limited cutaneous disorder that affects young individuals and may be overlooked or misdiagnosed due to its transient nature. A RASopathy that is known to be associated with JXG is neurofibromatosis type 1 (NF1). JXG in NF1 has also been reported in association with a juvenile myelomonocytic leukemia (JMML). As RASopathies, both NS and NF1 have an increased incidence of JMML. We report a 10-month-old female with NS who has a PTPN11 pathogenic variant resulting in a heterozygous SHP2 p.Y62D missense mutation. She was found to have numerous, small, yellow-pink smooth papules that were histopathologically confirmed to be JXG. In understanding the common underlying pathogenetic dysregulation of the Ras/MAPK pathway in both NS and NF1, this report suggests a possible molecular association for why NS individuals may be predisposed to JXG.


Asunto(s)
Predisposición Genética a la Enfermedad , Leucemia Mielomonocítica Juvenil/genética , Síndrome de Noonan/genética , Proteína Tirosina Fosfatasa no Receptora Tipo 11/genética , Xantogranuloma Juvenil/genética , Femenino , Humanos , Lactante , Leucemia Mielomonocítica Juvenil/complicaciones , Leucemia Mielomonocítica Juvenil/patología , Mutación Missense/genética , Neurofibromina 1/genética , Síndrome de Noonan/complicaciones , Síndrome de Noonan/patología , Fenotipo , Xantogranuloma Juvenil/complicaciones , Xantogranuloma Juvenil/patología , Proteínas ras/genética
3.
Dermatol Clin ; 39(2): 319-336, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33745643

RESUMEN

This article discusses the histologic findings in key nail unit diseases, including inflammatory, infectious, and neoplastic conditions. The emphasis is on clinicopathologic correlates, best practices to demonstrate the relevant histopathologic features, and pitfalls in diagnosis. Understanding the pathology of these disorders enhances clinical acumen and may affect the choice of biopsy procedures and treatment measures, with the outcome of better clinical care for patients with nail disease.


Asunto(s)
Enfermedades de la Uña , Uñas , Humanos
4.
J Cutan Pathol ; 48(6): 750-757, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33350497

RESUMEN

BACKGROUND: Data regarding ethical/professional issues affecting dermatopathologists are lacking despite their importance in establishing policy priorities and educational content for dermatopathology. METHODS: A 14-item cross-sectional survey about ethical/professional issues in dermatopathology was distributed over e-mail to members of the American Society of Dermatopathology from June to September 2019. RESULTS: Two hundred sixteen surveys were completed, with a response rate of 15.3%. Respondents ranked appropriate and fair utilization of healthcare resources (n = 83 or 38.6%) as the most often encountered ethical/professional issue. Conflict of interest was ranked as the most urgent or important ethical/professional issue (n = 83 or 39.3%). One hundred thirty-three (61.6%) respondents felt "somewhat" or "not at all" well equipped to handle ethical dilemmas in practice and 47 (22.8%) respondents identified a major or extreme burden (eg, have considered resigning/retiring) due to ethical challenges. CONCLUSIONS: Areas of priority in ethics and professionalism issues can guide future policy and educational content in dermatopathology.


Asunto(s)
Dermatología/organización & administración , Patología/organización & administración , Profesionalismo/ética , Sociedades Médicas/tendencias , Conflicto de Intereses , Estudios Transversales , Femenino , Humanos , Masculino , Aceptación de la Atención de Salud/estadística & datos numéricos , Asignación de Recursos/ética , Estados Unidos
5.
Skin Appendage Disord ; 130(43): 1-4, 2021 Dec 08.
Artículo en Inglés | MEDLINE | ID: mdl-35127838

RESUMEN

Onychomycosis is the most common nail condition seen in clinical practice, with significant impact on quality of life. Clinical examination alone is insufficient for accurate diagnosis, but mycological confirmation can be challenging during the COVID-19 pandemic. In this letter, a multidisciplinary panel of dermatologists, a podiatrist, dermatopathologists, and a mycologist, discuss considerations for mycological sampling during the pandemic.

6.
Cancer Cell ; 34(1): 56-68.e9, 2018 07 09.
Artículo en Inglés | MEDLINE | ID: mdl-29990501

RESUMEN

Loss of the CDKN2A tumor suppressor is associated with melanoma metastasis, but the mechanisms connecting the phenomena are unknown. Using CRISPR-Cas9 to engineer a cellular model of melanoma initiation from primary human melanocytes, we discovered that a lineage-restricted transcription factor, BRN2, is downstream of CDKN2A and directly regulated by E2F1. In a cohort of melanocytic tumors that capture distinct progression stages, we observed that CDKN2A loss coincides with both the onset of invasive behavior and increased BRN2 expression. Loss of the CDKN2A protein product p16INK4A permitted metastatic dissemination of human melanoma lines in mice, a phenotype rescued by inhibition of BRN2. These results demonstrate a mechanism by which CDKN2A suppresses the initiation of melanoma invasion through inhibition of BRN2.


Asunto(s)
Movimiento Celular , Inhibidor p16 de la Quinasa Dependiente de Ciclina/genética , Proteínas de Homeodominio/genética , Pérdida de Heterocigocidad , Neoplasias Pulmonares/genética , Melanocitos/metabolismo , Melanoma/genética , Factores del Dominio POU/genética , Neoplasias Cutáneas/genética , Activación Transcripcional , Animales , Línea Celular Tumoral , Inhibidor p16 de la Quinasa Dependiente de Ciclina/metabolismo , Factor de Transcripción E2F1/genética , Factor de Transcripción E2F1/metabolismo , Femenino , Regulación Neoplásica de la Expresión Génica , Proteínas de Homeodominio/metabolismo , Humanos , Neoplasias Pulmonares/metabolismo , Neoplasias Pulmonares/secundario , Masculino , Melanocitos/patología , Melanoma/metabolismo , Melanoma/secundario , Ratones Endogámicos NOD , Invasividad Neoplásica , Factores del Dominio POU/metabolismo , Mutación Puntual , Proteínas Proto-Oncogénicas B-raf/genética , Transducción de Señal , Neoplasias Cutáneas/metabolismo , Neoplasias Cutáneas/patología
8.
J Cutan Pathol ; 44(9): 749-756, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28589672

RESUMEN

BACKGROUND: There are limited data on nail histopathology techniques. The objective of this study was to examine nail histopathology techniques currently in use internationally. METHODS: An online survey was sent to the European Nail Society and Council for Nail Disorders during 2015-2016. RESULTS: There were 57 respondents, from twenty countries comprising dermatologists, podiatrists and pathologists. Specimens were unmarked or marked using ink or a suture and fixed in 10% formalin, from 6 to 48 hours before embedding in paraffin wax (90% [17/19]), liquid nitrogen (frozen section, 1/19) and 2-hydroxyethylmethacrylate (plastic, 1/19). Nail softening was undertaken by 71% (17/24) of respondents for 6 to 48 hours using Mollifex Gurr (12.5%, 3/24), 10% potassium hydroxide solution (12.5%, 3/24) or 10% potassium thioglycolate cream (12.5%, 3/24). Section thickness was 4 to 9 µm (62.5%), using a steel microtome (92%,12/13) on glass slides (91.6%, 11/12). Hematoxylin and eosin (H&E) was routine for all biopsies and Periodic acid Schiff (PAS) for fungus. The favored stain for differentiating melanin and hemoglobin was Fontana-Masson (60%, 6/10). For pigmented lesions, Melan-A was always employed by all respondents (9/9). CONCLUSION: Nail histopathology processing has some small variations from normal skin processing.


Asunto(s)
Técnicas Histológicas/métodos , Enfermedades de la Uña/diagnóstico , Uñas/patología , Patología Clínica/métodos , Fijación del Tejido/métodos , Citodiagnóstico/métodos , Humanos , Encuestas y Cuestionarios
9.
J Am Acad Dermatol ; 73(5): 821-8, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26321388

RESUMEN

BACKGROUND: Cytarabine-induced toxicity manifests as various cutaneous morphologies. A generalized papular purpuric eruption has not been well described. OBJECTIVES: We aimed to characterize a distinct cytarabine-related eruption. METHODS: We reviewed all cases of cytarabine-related toxicity with papular purpuric eruptions or violaceous erythema at the University of California, San Francisco between 2006 and 2011. RESULTS: Sixteen cases were identified. The eruption began as erythematous papules that evolved into coalescing purpuric papules and plaques. It had affinity for intertriginous areas, neck, ears, and scalp. Pruritus was common, but no systemic complications were documented. Thirteen patients (81.3%) developed the eruption after completion of chemotherapy. Differential diagnosis often included viral exanthem (62.5%), drug eruption (50%), and vasculitis (37.5%). Histopathology was nonspecific but commonly demonstrated sparse lymphocytic infiltrates, spongiosis, and/or red cell extravasation. Importantly, the eruption was neither predicted by past cytarabine exposure nor predictive of future recurrence. LIMITATIONS: This is a review of cases from a single institution. Observation was limited to acute hospitalization, however, charts were reviewed for subsequent reactions on rechallenge. CONCLUSIONS: The eruption described herein represents a specific skin-limited reaction to cytarabine. Awareness of its characteristic morphology, distribution, and timeline will aid in clinical diagnosis. Reassurance concerning its benign nature will prevent unnecessary intervention or cessation of chemotherapy.


Asunto(s)
Antimetabolitos Antineoplásicos/efectos adversos , Citarabina/efectos adversos , Erupciones por Medicamentos/patología , Adulto , Anciano , Diagnóstico Diferencial , Erupciones por Medicamentos/etiología , Eritema/inducido químicamente , Exantema/diagnóstico , Exantema/virología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Prurito/inducido químicamente , Púrpura/inducido químicamente , Enfermedades Cutáneas Vasculares/diagnóstico , Vasculitis/diagnóstico , Adulto Joven
10.
Semin Cutan Med Surg ; 34(2): 101-8, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26176288

RESUMEN

Longitudinal melanonychia originates from pigmented and/or melanocytic lesions of the nail unit. It may be a less-common entity encountered in dermatologic practice, but it is often a vexing one. Lesions occurring at this location present particular problems due to the unfamiliarity with clinical assessment, their relative inaccessibility, requiring more surgical finesse, and the lack of experience with histopathologic examination. Obtaining a specimen sufficient for interpretation is one of the main impediments to successful diagnosis in this setting. Most pigmented bands are benign, due to more common entities such as melanocytic activation, lentigo, and/or a nevus; however, deciding which ones are due to melanoma is of the utmost importance and can be difficult. Some examples of melanoma at this site are amelanotic, which are more challenging to recognize clinically, and usually lead to significant delays in diagnosis. In order to provide optimal patient care in this setting, it is very important that the physician has an understanding of the unique clinical, surgical, and pathologic issues relating to diagnosis of melanocytic neoplasms at this site, and there is communication between the clinician and the pathologist.


Asunto(s)
Melanoma/patología , Enfermedades de la Uña/patología , Trastornos de la Pigmentación/patología , Neoplasias Cutáneas/patología , Biopsia , Humanos
11.
Pediatr Radiol ; 45(10): 1515-21, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25916383

RESUMEN

BACKGROUND: The absence of a discrete mass, surrounding signal abnormality and solid enhancement are imaging features that have traditionally been used to differentiate soft-tissue arteriovenous malformations from vascular tumors on MRI. We have observed that these findings are not uncommon in arteriovenous malformations, which may lead to misdiagnosis or inappropriate treatment. OBJECTIVE: To estimate the frequency of atypical MRI features in soft-tissue arteriovenous malformations and assess their relationship to lesion size, location, tissue type involved and vascular architecture. MATERIALS AND METHODS: Medical records, MRI and histopathology were reviewed in consecutive patients with soft-tissue arteriovenous malformations in a multidisciplinary vascular anomalies clinic. Arteriovenous malformations were divided into those with and without atypical MRI findings (perilesional T2 signal abnormality, enhancement and/or a soft-tissue mass). Lesion location, size, tissue involved and vascular architecture were also compared between groups. Tissue stains were reviewed in available biopsy or resection specimens to assess relationships between MRI findings and histopathology. RESULTS: Thirty patients with treatment-naïve arteriovenous malformations were included. Fifteen lesions demonstrated atypical MRI. There was no difference in age, gender, lesion size or involved body part between the groups. However, more than half of the atypical lesions demonstrated multicompartmental involvement, and tiny intralesional flow voids were more common in atypical arteriovenous malformations. Histopathology also differed in atypical cases, showing densely packed endothelial cells with connective tissue architectural distortion and edema. CONCLUSION: Arteriovenous malformations may exhibit features of a vascular tumor on MRI, particularly when multicompartmental and/or containing tiny internal vessels. These features are important to consider in suspected fast-flow vascular malformations and may have implications with respect to their treatment.


Asunto(s)
Malformaciones Arteriovenosas/patología , Imagen por Resonancia Magnética , Adolescente , Adulto , Niño , Preescolar , Estudios de Cohortes , Medios de Contraste , Femenino , Gadolinio , Humanos , Aumento de la Imagen , Lactante , Masculino , Persona de Mediana Edad , Músculos/irrigación sanguínea , Músculos/patología , Variaciones Dependientes del Observador , Reproducibilidad de los Resultados , Estudios Retrospectivos , Piel/irrigación sanguínea , Piel/patología , Adulto Joven
12.
Int J Dermatol ; 54(6): 617-25, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25773292

RESUMEN

IMPORTANCE: Cutaneous granulomas without an identifiable infectious etiology are a rare manifestation of primary immunodeficiency (ID). These cutaneous lesions can be misdiagnosed, often as sarcoidosis, when the skin findings precede the diagnosis of immunodeficiency. OBJECTIVE: We present four cases from our institution and review the literature in order to emphasize the clinical relevance of this association, discuss the histologic and immunohistochemical features, and explore possible pathogenic mechanisms of granuloma formation. EVIDENCE REVIEW: We retrospectively reviewed case reports of all patients presenting with cutaneous granulomas in the setting of primary immunodeficiency. Cases with insufficient information to confirm an immunodeficiency state were excluded. Four patients from our clinic were included, for 54 total cases. FINDINGS: The majority of cutaneous granulomas are seen in three types of immunodeficiencies: ataxia-telangiectasia, severe combined immunodeficiency, and combined variable immunodeficiency. Twenty-six percent of patients developed cutaneous granulomas prior to their immunodeficiency diagnosis. Histologically, various granulomatous patterns have been described. Immunohistochemistry revealed a CD4+/CD8+ lymphocyte ratio of less than or equal to 1 in our four patients, which may help differentiate cutaneous granulomas in primary ID from sarcoidal granulomas that typically show a CD4+ predominance. CONCLUSIONS AND RELEVANCE: Cutaneous granulomas are a rare manifestation of primary ID and occur predominantly in immunodeficiencies that affect T and B cell compartments.


Asunto(s)
Granuloma/inmunología , Síndromes de Inmunodeficiencia/complicaciones , Enfermedades de la Piel/inmunología , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Adulto Joven
14.
J Cutan Pathol ; 41(4): 353-63, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24329979

RESUMEN

BACKGROUND: SOX-10 expression can be demonstrated by immunohistochemistry in salivary gland myoepitheliomas, but its expression in cutaneous myoepitheliomas and in cutaneous mixed tumors with prominent myoepithelial cells has not been studied. METHODS: We assessed the staining pattern of SOX-10 in five cutaneous myoepitheliomas and six cutaneous mixed tumors with a prominent myoepithelial component among both the myoepithelial cells and cells lining lumens. In addition, we examined the staining of S100, microphthalmia-associated transcription factor (MiTF), keratin cocktail, HMK903, smooth muscle actin (SMA) and epithelial membrane antigen (EMA). RESULTS: SOX-10 positivity was seen in three of five (60%) cutaneous myoepitheliomas and in the myoepithelial cells of all cutaneous mixed tumors. SOX-10 expression on the cells lining the glandular structures in mixed tumors was variable. All myoepitheliomas and mixed tumors stained positively with S100 and negatively with MiTF. Pan-keratin, HMK903, SMA and EMA showed variable expression. CONCLUSIONS: SOX-10 is a relatively reliable marker for staining cutaneous myoepitheliomas. Cutaneous myoepitheliomas are notoriously difficult to diagnose, and the addition of SOX-10 to the repertoire of stains that can label this tumor is of practical utility. These results further support that cutaneous myoepitheliomas and cutaneous mixed tumors exist on a morphologic and immunophenotypic spectrum.


Asunto(s)
Biomarcadores de Tumor/biosíntesis , Regulación Neoplásica de la Expresión Génica , Tumor Mixto Maligno , Mioepitelioma , Proteínas de Neoplasias/biosíntesis , Factores de Transcripción SOXE/biosíntesis , Neoplasias Cutáneas , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Tumor Mixto Maligno/metabolismo , Tumor Mixto Maligno/patología , Mioepitelioma/metabolismo , Mioepitelioma/patología , Estudios Retrospectivos , Neoplasias de las Glándulas Salivales/metabolismo , Neoplasias de las Glándulas Salivales/patología , Neoplasias Cutáneas/metabolismo , Neoplasias Cutáneas/patología
15.
Clin Dermatol ; 31(5): 594-601, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24079589

RESUMEN

Melanonychia is black or brown pigmentation that appears in the fingernails and toenails. The pigment can come from exogenous sources, such as bacteria or fungal infection, tar, or blood. Endogenous causes include aberrant melanin production in the nail bed, resulting in a longitudinal presentation. Melanonychia can indicate the presence of cancerous growths, as well as infection. Diagnostic measures, including dermatoscopy, biopsy, and histopathology, can determine the cause and direct the course of treatment. Malignant lesions should be excised, and underlying infections should be addressed with antibiotics or antifungals. Benign lesions and hyperpigmentation may benefit from a wait-and-see approach.


Asunto(s)
Dermoscopía , Hiperpigmentación/diagnóstico , Hiperpigmentación/etiología , Melanoma/diagnóstico , Enfermedades de la Uña/diagnóstico , Enfermedades de la Uña/etiología , Uñas/patología , Neoplasias Cutáneas/diagnóstico , Biopsia , Diagnóstico Diferencial , Dedos , Humanos , Hiperpigmentación/cirugía , Melaninas , Melanoma/cirugía , Enfermedades de la Uña/cirugía , Neoplasias Cutáneas/cirugía , Dedos del Pie , Espera Vigilante
16.
An Bras Dermatol ; 88(2): 309-13, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23739699

RESUMEN

This statement, focused on melanonychia and nail plate dermoscopy, is intended to guide medical professionals working with melanonychia and to assist choosing appropriate management for melanonychia patients. The International Study Group on Melanonychia was founded in 2007 and currently has 30 members, including nail experts and dermatopathologists with special expertise in nails. The need for common definitions of nail plate dermoscopy was addressed during the Second Meeting of this Group held in February 2008. Prior to this meeting and to date (2010) there have been no evidence-based guidelines on the use of dermoscopy in the management of nail pigmentation.


Asunto(s)
Dermoscopía/métodos , Enfermedades de la Uña/diagnóstico , Trastornos de la Pigmentación/diagnóstico , Consenso , Diagnóstico Diferencial , Humanos , Masculino , Melanoma/diagnóstico , Neoplasias Cutáneas/diagnóstico
18.
J Cutan Pathol ; 39(4): 444-8, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22443395

RESUMEN

We report two cases of eruptive tumors of the follicular infundibulum (TFI) with an unusual clinical presentation which has not been described previously in literature. In both cases, the appearance was strikingly similar, consisting of multiple asymptomatic hypopigmented macules on the buttocks of two Black African males, aged 38 and 55 years old. In both cases, the eruption had evolved over several months. The individual lesions were of similar size, approximately 1 cm, with irregular and ill-defined borders. Histopathological examination revealed a superficial and horizontal plate-like proliferation of keratinocytes emanating from the epidermis with multiple slender attachments. Pale keratinocytes were present within the epithelial plates. A Fontana stain showed a loss of melanin pigment from the epithelial plates. Orcein (elastic) stain highlighted an increase of the number of the elastic fibers surrounding the tumor. On the basis of these findings, a diagnosis of eruptive TFI was established for both cases. Among the various presentations of TFI, only the eruptive variant appears to be clinically distinctive, with asymptomatic hypopigmented macules usually located on the face, neck and upper trunk. Eruptive TFI should also be added to the clinical differential diagnosis of multiple hypopigmented macules on the buttocks of Black patients.


Asunto(s)
Población Negra , Epidermis , Trastornos de la Pigmentación , Neoplasias Cutáneas , Adulto , Proliferación Celular , Diagnóstico Diferencial , Tejido Elástico/metabolismo , Epidermis/metabolismo , Epidermis/patología , Humanos , Queratinocitos/metabolismo , Queratinocitos/patología , Masculino , Melaninas/metabolismo , Persona de Mediana Edad , Trastornos de la Pigmentación/metabolismo , Trastornos de la Pigmentación/patología , Neoplasias Cutáneas/metabolismo , Neoplasias Cutáneas/patología
20.
Am J Dermatopathol ; 33(8): e91-3, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22024572

RESUMEN

A 45-year-old woman presented for evaluation of a solitary pruritic nodule on the abdomen that suddenly appeared 3 weeks before. She was healthy without a significant medical history, travel history, exposures, medications, or pets. She reported that she consumed sushi at least weekly in the city of San Francisco. A punch biopsy revealed a superficial and deep perivascular and interstitial infiltrates consisting of lymphocytes, plasma cells, and many eosinophils. Most notably, there was a parasite centered in the reticular dermis with prominent lateral chords, a well-developed muscular esophagus, and an intestine that contained a brush border and multinucleate cells. Evaluation of these histological sections by the Centers for Disease Control and Prevention determined the parasite to be a nematode of the genus Gnathostoma. The patient underwent a systemic work-up for gnathostomiasis, including imaging, and no other abnormalities were found. She completed a 3-week course of albendazole and has remained asymptomatic since the biopsy of her abdominal lesion. Although gnathostomiasis is often a systemic illness, this patient did well with apparently only localized cutaneous disease. Gnathostomiasis should be considered in patients who present with nonspecific papules and nodules, especially when there is a history of frequent consumption of raw fish.


Asunto(s)
Contaminación de Alimentos , Gnathostoma/aislamiento & purificación , Gnathostomiasis/parasitología , Alimentos Marinos/efectos adversos , Piel/parasitología , Albendazol/uso terapéutico , Animales , Antinematodos/uso terapéutico , Biopsia , Femenino , Gnathostomiasis/tratamiento farmacológico , Gnathostomiasis/patología , Humanos , Persona de Mediana Edad , Piel/patología , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA